The role of cytochrome P450 enzymes in COVID-19 pathogenesis and therapy
G Wang, B Xiao, J Deng, L Gong, Y Li, J Li… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) has become a new public health crisis threatening
the world. Dysregulated immune responses are the most striking pathophysiological …
the world. Dysregulated immune responses are the most striking pathophysiological …
Pharmacogenetics and precision medicine approaches for the improvement of COVID-19 therapies
M Biswas, N Sawajan, T Rungrotmongkol… - Frontiers in …, 2022 - frontiersin.org
Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …
pandemic situations without establishing clinical effectiveness or tailoring safety. A …
Rapid and accurate identification of SARS-CoV-2 variants using real time PCR assays
GA Borillo, RM Kagan, EM Marlowe - Frontiers in cellular and …, 2022 - frontiersin.org
Background Genomic surveillance efforts for SARS-CoV-2 are needed to understand the
epidemiology of the COVID-19 pandemic. Viral variants may impact routine diagnostic …
epidemiology of the COVID-19 pandemic. Viral variants may impact routine diagnostic …
Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the …
GPWC Yuda, N Hanif, A Hermawan - DARU Journal of Pharmaceutical …, 2024 - Springer
Background COVID-19 is an infectious disease caused by SARS-CoV-2, a close relative of
SARS-CoV. Several studies have searched for COVID-19 therapies. The topics of these …
SARS-CoV. Several studies have searched for COVID-19 therapies. The topics of these …
Favipiravir-based treatment for outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
SH Lan, CC Lai, SP Chang, LC Lu… - Expert Review of …, 2022 - Taylor & Francis
Background This meta-analysis of randomized controlled trials (RCTs) investigated the
clinical efficacy and safety of favipiravir for patients with mild-to-critical COVID-19. Methods …
clinical efficacy and safety of favipiravir for patients with mild-to-critical COVID-19. Methods …
Candida pneumonia with lung abscess as a complication of severe COVID-19 pneumonia
A Abdelhadi, A Kassem - International medical case reports journal, 2021 - Taylor & Francis
A South Asian male patient in his mid-forties presented with symptoms of severe 2019-nCoV
(COVID-19) and recent brain infarction. Subsequently, he was found to have evidence of …
(COVID-19) and recent brain infarction. Subsequently, he was found to have evidence of …
Pengaruh Favipiravir dan Remdesivir Pada Pasien Covid-19 dengan Komorbid Penyakit Kardiovaskular & Hipertensi Terhadap Luaran Klinis Di RSUP Fatmawati …
M Nasarah, H Utami, Y Sumiyati… - Poltekita: Jurnal Ilmu …, 2022 - jurnal.poltekkespalu.ac.id
Tujuan dari penelitian ini adalah untuk menganalisis dan mengevaluasi hubungan antivirus
favipiravir dan remdesivir pada pasien COVID-19 dengan komorbid penyakit kardiovaskular …
favipiravir dan remdesivir pada pasien COVID-19 dengan komorbid penyakit kardiovaskular …
Efficacy and safety of Remdesivir in patients with Covid-19: A review of systematic reviews and meta-analyses
Methods: An electronic search was conducted in PubMed, Scopus, Cochrane Library, and
Web of Science databases up to December 2021. In addition, other databases were …
Web of Science databases up to December 2021. In addition, other databases were …